Literature DB >> 26912742

The Clot Thickens in Atherosclerosis.

Nigel Mackman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26912742      PMCID: PMC4772167          DOI: 10.1161/ATVBAHA.116.307094

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  12 in total

1.  Rivaroxaban in patients with a recent acute coronary syndrome.

Authors:  Jessica L Mega; Eugene Braunwald; Stephen D Wiviott; Jean-Pierre Bassand; Deepak L Bhatt; Christoph Bode; Paul Burton; Marc Cohen; Nancy Cook-Bruns; Keith A A Fox; Shinya Goto; Sabina A Murphy; Alexei N Plotnikov; David Schneider; Xiang Sun; Freek W A Verheugt; C Michael Gibson
Journal:  N Engl J Med       Date:  2011-11-13       Impact factor: 91.245

2.  Factor XII regulates the pathological process of thrombus formation on ruptured plaques.

Authors:  Marijke J E Kuijpers; Paola E J van der Meijden; Marion A H Feijge; Nadine J A Mattheij; Frauke May; José Govers-Riemslag; Joost C M Meijers; Johan W M Heemskerk; Thomas Renné; Judith M E M Cosemans
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-22       Impact factor: 8.311

3.  Role of the intrinsic coagulation pathway in atherogenesis assessed in hemophilic apolipoprotein E knockout mice.

Authors:  J Khallou-Laschet; G Caligiuri; E Tupin; A-T Gaston; B Poirier; E Groyer; D Urbain; S Maisnier-Patin; R Sarkar; S V Kaveri; S Lacroix-Desmazes; A Nicoletti
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-05-26       Impact factor: 8.311

4.  Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice.

Authors:  Florian Bea; Joerg Kreuzer; Michael Preusch; Sandra Schaab; Berend Isermann; Michael E Rosenfeld; Hugo Katus; Erwin Blessing
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-09-21       Impact factor: 8.311

5.  Novel insights into the development of atherosclerosis in hemophilia A mouse models.

Authors:  D R Fabri; E V de Paula; D S P Costa; J M Annichino-Bizzacchi; V R Arruda
Journal:  J Thromb Haemost       Date:  2011-08       Impact factor: 5.824

Review 6.  Tissue Factor and Atherothrombosis.

Authors:  Kohei Tatsumi; Nigel Mackman
Journal:  J Atheroscler Thromb       Date:  2015-05-27       Impact factor: 4.928

7.  Factor XI antisense oligonucleotide for prevention of venous thrombosis.

Authors:  Harry R Büller; Claudette Bethune; Sanjay Bhanot; David Gailani; Brett P Monia; Gary E Raskob; Annelise Segers; Peter Verhamme; Jeffrey I Weitz
Journal:  N Engl J Med       Date:  2014-12-07       Impact factor: 91.245

8.  Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques.

Authors:  Maurits L van Montfoort; Marijke J E Kuijpers; Véronique L Knaup; Sanjay Bhanot; Brett P Monia; Joris J T H Roelofs; Johan W M Heemskerk; Joost C M Meijers
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-19       Impact factor: 8.311

Review 9.  The impact of blood coagulability on atherosclerosis and cardiovascular disease.

Authors:  R Loeffen; H M H Spronk; H ten Cate
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

10.  Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner.

Authors:  Julian I Borissoff; Jeroen J T Otten; Sylvia Heeneman; Peter Leenders; René van Oerle; Oliver Soehnlein; Sarah T B G Loubele; Karly Hamulyák; Tilman M Hackeng; Mat J A P Daemen; Jay L Degen; Hartmut Weiler; Charles T Esmon; Joanne van Ryn; Erik A L Biessen; Henri M H Spronk; Hugo ten Cate
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more
  1 in total

1.  Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis.

Authors:  R H Olie; P E J van der Meijden; H M H Spronk; H Ten Cate
Journal:  Handb Exp Pharmacol       Date:  2022
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.